| Trial registration number
|
IRCT20191228045924N2 |
Full text link
Last imported at : Nov. 22, 2021, 9 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
http://en.irct.ir/trial/60065
|
First author
Last imported at : Nov. 22, 2021, 9 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Dr. Majid Ghayour Mobarhan
|
Contact
Last imported at : Nov. 22, 2021, 9 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
GhayourM@mums.ac.ir
|
Registration date
Last imported at : Nov. 22, 2021, 9 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
2021-11-22
|
Recruitment status
Last imported at : Jan. 20, 2022, 1:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Completed
|
Study design
Last imported at : Nov. 22, 2021, 9 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
RCT
|
Allocation
Last imported at : Nov. 22, 2021, 9 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Randomized
|
Design
Last imported at : Nov. 22, 2021, 9 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Parallel
|
Masking
Last imported at : Nov. 22, 2021, 9 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Blind label
|
Center
Last imported at : Nov. 22, 2021, 9 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
single-center
|
Study aim
Last imported at : Nov. 22, 2021, 9 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Treatment
|
Inclusion criteria
Last imported at : Nov. 22, 2021, 9 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Outpatient COVID-19 patients who confirmed by PCR or HRCT referred to pulmonary clinic
SPO2 is between 70-96 after taking off the mask
|
Exclusion criteria
Last imported at : Nov. 22, 2021, 9 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Pregnancy
Severe impairment of liver and heart
Renal insufficiency including severe renal impairment
G6PD enzyme deficiency
|
Number of arms
Last imported at : Nov. 22, 2021, 9 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
2
|
Funding
Last imported at : Nov. 22, 2021, 9 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Mashhad University of Medical Sciences
|
Inclusion age min
Last imported at : Nov. 22, 2021, 9 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
18
|
Inclusion age max
Last imported at : Nov. 22, 2021, 9 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
100
|
Countries
Last imported at : Nov. 22, 2021, 9 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Iran
|
Type of patients
Last imported at : Nov. 22, 2021, 9 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Moderate/severe disease at enrollment
|
Severity scale
Last imported at : Nov. 22, 2021, 9 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
4: Moderate/severe disease at enrollment
|
Total sample size
Last imported at : Nov. 22, 2021, 9 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
240
|
primary outcome
Last imported at : Nov. 22, 2021, 9 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Oxygen pressure saturation
Respiratory Rate
Headache
Cough
Shivery
Chest pain
Vomiting
Diarrhea
Fever
|
Notes
Last imported at : Nov. 22, 2021, 9 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
|
Phase
Last imported at : Nov. 22, 2021, 9 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Phase 4
|
Arms
Last imported at : Nov. 22, 2021, 9 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
[{"arm_notes": "", "treatment_id": 2056, "treatment_name": "Complementary materials+methylene blue", "treatment_type": "Nutrition+others pharmacological treatment", "pharmacological_treatment": "Non pharmacological treatment+pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]
|